Abstract:
In global scenario the cases of bronchial asthma were increasing tremendously and were estimated to be approximately 4.5 percent. There are about 334 million patients suffering with bronchial asthma that is affecting almost all age groups of patients across the world. In India around 15-20 million people were affected with bronchial asthma. The prevalence of asthma is increasing with time and additional 100 million people will be expected to develop asthma by the year 2025. The alarming rise in the prevalence of
Tamaka Shwasa can be accounted to factors such as Atmospheric pollution, rapid environmental changes, adaptation of newer dietetic preparations and tremendous psychological stress. The proposed study was undertaken to access the efficacy of
Shatyadi Churna and
aktam lavan tail snehana and
swedan karma in the management of
Tamaka shwasa. The clinical trial was carried out from OPD and IPD of N.I.A Hospital and Bombaywala hospital in Jaipur (Rajasthan) on total of 30 patients and randomly divided into three groups with 10 patients in each group. In 1
st group patients were subjected to
snehana and
swedan karma on
Uraha Pradesh for 30 days. In 2
nd group patients were treated with
Shatyadi Churna with dose of 5 grams with honey B.D for 30 days whereas in 3
rd group the patients were treated with
snehana and
swedan and
Shatyadi Churna both. The data collected was then statistically analyzed. It was observed that in Group I, 31.50% symptomatic relief was noticed, in Group II 58.22% symptomatic relief was noticed whereas in Group III 72.22% symptomatic relief was noticed. Hence fastest and maximum improvement was found in Group III.